(2E)-1-(2,4-dimethoxyphenyl)-3-(3-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

3-Bromo-9-(1-naphthyl)-9H-carbazole>97.0%(GC)200mg

tert-Butyl 7-bromo-5-oxa-2-azaspiro[3.4]octane-2-carboxylate, 95+%, 500mg

(4-Fluoro-3-(pyrrolidine-1-carbonyl)phenyl)boronic acid, 95.0%, 10g

5-Methoxyindole, min. 98%, for synthesis, 25 g, glass packaging

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-bromopent-4-enoic acid, 95+%, 100mg

Piperazine-2-carboxylic acid dihydrochloride, 98.0%, 100g

1-(2-Chloro-6-fluoro-benzyl)-1 H -pyrazol-4-ylamine; hydrochloride, 95.0%, 250mg

PEG3-O-CH2COOH, 95%, 10g

1,5,7-Trimethyl-1H-indole-2-carboxylic acid, 97%, 1g

N-methoxy-N,3-dimethyl-4-nitrobenzamide, 95.0%, 10g

4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexenyl]methyl]-1-piperazinyl]benzoic Acid Hydrochloride, 97.0%, 1g

4-bromo-2-chloronicotinonitrile, 95%, 10g